Unternehmen
HBOX THERAPIES GMBH
Weiter entdecken
Ähnliche Beiträge
Projekt
→
Response-aware molecular subtyping of ulcerative colitis for patient stratification via interpretable machine learning
Ulcerative colitis (UC) is a heterogeneous inflammatory disease with diverse molecular features and variable responses to biologi… Beitrag ansehen →
Projekt
→
Polyclonal anti-tumor immunity by engineered human T cells
Adoptive T cell therapies are a new class of living drugs, achieving durable results in a subset of patients with aggressive mali… Beitrag ansehen →
Projekt
→
Cancer cell plasticity on targeted therapy
Novel cancer molecular-targeted therapies allow to significantly prolong the survival of cancer patients. However, the inevitable… Beitrag ansehen →
Projekt
→
Deciphering the radiobiology of targeted radionuclide therapy: from subcellular to intra-tumoural analyses
Background and unmet need Targeted radionuclide therapies (TRTs) are a promising modality to treat patients with metastasized can… Beitrag ansehen →
Projekt
→
The brain erythropoietin cycle as driver of adaptive neuroplasticity via functional hypoxia
Cognitive disability and decline play key roles in neuropsychiatric conditions but lack effective therapies. Erythropoietin (EPO)… Beitrag ansehen →
Projekt
→
Dissecting the neutrophil-cancer cell interactome in the metastatic bone niche
Bone is one of the most common organs for solid tumour metastasis. 75% of patients with late-stage breast cancer develop recurren… Beitrag ansehen →
Passend zu diesem Beitrag